Key highlights:
- The Australian Therapeutic Goods Administration (TGA) found a significant quantity of illegal e-cigarettes and nicotine pouches in western Sydney.
- The black market value of these goods is estimated to be over $360,000 ($230,000 USD).
- Authorities have accused these products of violating the Therapeutic Goods Act 1989.
According to a report by Pharmacy Daily on March 27th, the Therapeutic Goods Administration (TGA) seized over 5,000 e-cigarettes and 7,000 nicotine pouches in the Penrith area of western Sydney. The black market value of the seized items is estimated to be over $360,000 ($230,000 USD).
The TGA has accused these products of being held or supplied illegally, in violation of the Therapeutic Goods Act 1989.
Currently, therapeutic e-cigarettes can only be sold in participating pharmacies for smoking cessation and nicotine dependence management, while nicotine pouches are classified as strictly controlled prescription drugs.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
